MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$5,131K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales of marketabl...
Other payables and accrued liabi...
Share-based compensation
Others
Negative Cash Flow Breakdown
Inventory
Purchases of marketable securiti...
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-5,627
-3,671
-3,464
-3,577
Depreciation of property and equipment
15
12
10
10
Interest income and unrealized gains from marketable securities
-7
-60
-
163
Share-based compensation
433
222
236
328
Accounts receivable
71
105
-
-
Inventory
650
1,673
584
-
Prepaid expenses and other assets
-69
-
7
336
Accounts payable and accrued liabilities
-
-
495
-
Change in long-term deposit
-
-
737
-
Other payables and accrued liabilities
835
395
-
-103
Net cash flows used in operating activities
-4,989
-5,053
-3,758
-3,841
Purchases of property and equipment
142
108
25
13
Purchase of marketable securities
-
-
3,008
48,000
Purchases of marketable securities
629
441
-
-
Proceeds from sales of marketable securities
5,250
6,500
1,500
3,301
Increase in long-term deposit
0
148
-
-
Increase in restricted deposit
8
806
-
-
Net cash flows provided by (used in) investing activities
4,471
4,997
-1,533
-44,712
Issuance of common stock and warrants, net
16
-
2,506
51,175
Exercise of options
-
-
0
1
Net cash flows provided by financing activities
16
-
2,506
51,176
Increase (decrease) in cash, cash equivalents and restricted cash
-502
-56
-2,785
2,623
Cash, cash equivalents and restricted cash at beginning of period
3,917
3,973
6,758
3,163
Cash, cash equivalents and restricted cash at end of period
3,415
3,917
3,973
6,758
Right-of-use assets obtained in exchange for lease liabilities
101
-
-
-
Cash and cash equivalents
3,152
-
-
-
Restricted cash
263
-
-
-
Cash, cash equivalents and restricted cash
3,415
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sales of
marketable securities
$5,250K
(-9.50%↓ Y/Y)
Issuance of common stock
and warrants, net
$16K
(-99.95%↓ Y/Y)
Net cash flows
provided by (used in)...
$4,471K
(117.10%↑ Y/Y)
Net cash flows
provided by financing...
$16K
(-99.95%↓ Y/Y)
Canceled cashflow
$779K
Increase (decrease) in
cash, cash...
-$502K
(-151.65%↓ Y/Y)
Canceled cashflow
$4,487K
Other payables and
accrued liabilities
$835K
(807.61%↑ Y/Y)
Share-based compensation
$433K
(-12.17%↓ Y/Y)
Prepaid expenses and
other assets
-$69K
(57.14%↑ Y/Y)
Depreciation of property and
equipment
$15K
(-44.44%↓ Y/Y)
Interest income and
unrealized gains from...
-$7K
(-105.88%↓ Y/Y)
Purchases of marketable
securities
$629K
(-98.03%↓ Y/Y)
Purchases of property and
equipment
$142K
(545.45%↑ Y/Y)
Increase in restricted
deposit
$8K
Net cash flows used
in operating...
-$4,989K
(8.41%↑ Y/Y)
Canceled cashflow
$1,359K
Net loss
-$5,627K
(7.77%↑ Y/Y)
Inventory
$650K
Accounts receivable
$71K
Buy us a coffee
Microbot Medical Inc. (MBOT)
Microbot Medical Inc. (MBOT)